Background. Growth factors are key inducers of fibrosis but can also mediate inflammatory responses resulting in increasing pleural effusion and acute respiratory distress syndrome. The primary aim of the study was to analyse growth factors release after performing chemical and mechanical pleurodesis in the first 48 hours at the patients with malignant pleural effusion. The secondary endpoints were to evaluate the effectiveness of the both pleurodeses, symptoms release and the quality of life of patients after the treatment
Objective: Malignant pleural effusions (MPE) are characterized by rapid reaccumulation, after tappin...
Background: Many patients with pneumonia develop pleural effusions. Pleural fluid vascular endotheli...
AbstractBackground42–77% of exudative pleural effusions are due to malignant diseases (Marel et al.,...
Background: Growth factors are key inducers of fibrosis but can also mediate inflammatory responses ...
Repeated thoracentesis may cause pleural inflammation and induce local release of proinfammatory cyt...
AbstractRecurrent pleural malignant effusion is a common problem which can be treated by inducing sy...
Thoracoscopic chemically induced pleurodesis in the treatment of malignant pleural effusion as a mod...
Metastatic or primary (mesothelioma) malignancy of the pleura often generates major pleura] effusio...
Metastatic or primary (mesothelioma) malignancy of the pleura often generates major pleura] effusion...
AbstractBackground42–77% of exudative pleural effusions are due to malignant diseases (Marel et al.,...
Malignant pleural effusions are a common complication of advanced malignancy, have a poor prognosis ...
Objectives: Patients with malignant pleural mesothelioma (MPM) or pleural metastases often present w...
Objectives: Patients with malignant pleural mesothelioma (MPM) or pleural metastases often present w...
Pleural effusion is a common clinical problem in everyday clinical practice. Vascular endothelial gr...
AbstractPleurodesis of malignant pleural effusion provides for a substantially better quality of lif...
Objective: Malignant pleural effusions (MPE) are characterized by rapid reaccumulation, after tappin...
Background: Many patients with pneumonia develop pleural effusions. Pleural fluid vascular endotheli...
AbstractBackground42–77% of exudative pleural effusions are due to malignant diseases (Marel et al.,...
Background: Growth factors are key inducers of fibrosis but can also mediate inflammatory responses ...
Repeated thoracentesis may cause pleural inflammation and induce local release of proinfammatory cyt...
AbstractRecurrent pleural malignant effusion is a common problem which can be treated by inducing sy...
Thoracoscopic chemically induced pleurodesis in the treatment of malignant pleural effusion as a mod...
Metastatic or primary (mesothelioma) malignancy of the pleura often generates major pleura] effusio...
Metastatic or primary (mesothelioma) malignancy of the pleura often generates major pleura] effusion...
AbstractBackground42–77% of exudative pleural effusions are due to malignant diseases (Marel et al.,...
Malignant pleural effusions are a common complication of advanced malignancy, have a poor prognosis ...
Objectives: Patients with malignant pleural mesothelioma (MPM) or pleural metastases often present w...
Objectives: Patients with malignant pleural mesothelioma (MPM) or pleural metastases often present w...
Pleural effusion is a common clinical problem in everyday clinical practice. Vascular endothelial gr...
AbstractPleurodesis of malignant pleural effusion provides for a substantially better quality of lif...
Objective: Malignant pleural effusions (MPE) are characterized by rapid reaccumulation, after tappin...
Background: Many patients with pneumonia develop pleural effusions. Pleural fluid vascular endotheli...
AbstractBackground42–77% of exudative pleural effusions are due to malignant diseases (Marel et al.,...